Overview

IV Iron Sucrose vs Oral FeSO4 in Treating IDA in Pediatric IBD

Status:
Withdrawn
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of intravenous iron sucrose in comparison to oral ferrous sulfate in improving iron deficiency anemia in children with inflammatory bowel disease.
Phase:
Phase 2
Details
Lead Sponsor:
Wayne State University
Collaborators:
American Regent, Inc.
Children's Hospital of Michigan
Luitpold Pharmaceuticals
Treatments:
Ferric Compounds
Ferric Oxide, Saccharated
Iron